During the past decade, Medipoint Hospitals Pvt. Ltd conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medipoint Hospitals Pvt. Ltd" #1 collaborator was "Iqvia Pty Ltd" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Medipoint Hospitals Pvt. Ltd" are "Diabetes" (1 trials), "Dyslipidemias" (1 trials), "Hepatitis" (1 trials), "Hepatitis C" (1 trials) and "Hypertension" (1 trials). Many other conditions were trialed in "Medipoint Hospitals Pvt. Ltd" in a lesser frequency.

Most popular intervention types in "Medipoint Hospitals Pvt. Ltd" are "Drug" (4 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "13-valent Pneumococcal conjugate vaccine" (1 trials), "Algeron" (1 trials), "Blood sample collection" (1 trials), "Pegasys" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medipoint Hospitals Pvt. Ltd" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Medipoint Hospitals Pvt. Ltd". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Medipoint Hospitals Pvt. Ltd, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Medipoint Hospitals Pvt. Ltd, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".